Latest Pharma Insights
The US VA And Alzheimer’s: A Misunderstood Decision
US Department of Veterans Affairs' head for pharmacy benefits management says her agency’s coverage of Leqembi and Aduhelm is actually...
Pink Sheet - May 31, 2023
US Department of Veterans Affairs' head for pharmacy benefits management says her agency’s coverage of Leqembi and Aduhelm is actually...
Pink Sheet - May 31, 2023
Janssen 340B Discount Growth Slowed In 2022 But Still Topped $6bn; Patient Assistance Jumps 24%
Janssen continues to pursue aggressive policies to reduce inappropriate use of 340B discounts. Firm estimates that 58% of list prices...
Pink Sheet - May 31, 2023
Janssen continues to pursue aggressive policies to reduce inappropriate use of 340B discounts. Firm estimates that 58% of list prices...
Pink Sheet - May 31, 2023
Travere Looks Ahead To Phase III In Homocystinuria
The latest data from a Phase I/II study shows that pegtibatinase can yield a rapid, sustained reduction in homocysteine, the...
Scrip - May 31, 2023
The latest data from a Phase I/II study shows that pegtibatinase can yield a rapid, sustained reduction in homocysteine, the...
Scrip - May 31, 2023
Minute Insight: Inbound Health Now Offers Post-Surgical Hospital Care At Patients’ Homes
The hospital-to-home care movement is rising, and Inbound Health wants to be at the forefront of enabling health systems and...
Medtech Insight - May 31, 2023
The hospital-to-home care movement is rising, and Inbound Health wants to be at the forefront of enabling health systems and...
Medtech Insight - May 31, 2023
FDA’s Power Morcellation Containment System Guidance Doc Finalized
The US FDA has finalized a guidance document that details performance assessment standards for power morcellation containment systems. The class...
Medtech Insight - May 31, 2023
The US FDA has finalized a guidance document that details performance assessment standards for power morcellation containment systems. The class...
Medtech Insight - May 31, 2023
Trials In Focus: Diverse Enrollment Lagging In Oncology, IQVIA Finds
Also, CRO Syneos Health appointed an executive to its newly created DE&I position, while Alterity started a new Phase II...
Scrip - May 31, 2023
Also, CRO Syneos Health appointed an executive to its newly created DE&I position, while Alterity started a new Phase II...
Scrip - May 31, 2023
Exec Chat: Abbott’s Burton Talks About Abbott’s Plans To Address Chronic Pain With SCS
Allen Burton, the medical director of Abbott’s neuromodulation business and a leader in pain medicine, talked to Medtech Insight about...
Medtech Insight - May 31, 2023
Allen Burton, the medical director of Abbott’s neuromodulation business and a leader in pain medicine, talked to Medtech Insight about...
Medtech Insight - May 31, 2023
Facility Inspection Leads To FDA Warning For iRhythm
The US FDA issued a warning letter to iRhythm Technologies related to its Zio cardiac monitor system after an August...
Medtech Insight - May 31, 2023
The US FDA issued a warning letter to iRhythm Technologies related to its Zio cardiac monitor system after an August...
Medtech Insight - May 31, 2023
Ulta Working To Combat Surging Retail Theft As Q1 Sales Rise 12.3%
Ulta Beauty says consumers are being more selective in their spending but show “continued willingness to splurge and treat themselves.”...
HBW Insight - May 31, 2023
Ulta Beauty says consumers are being more selective in their spending but show “continued willingness to splurge and treat themselves.”...
HBW Insight - May 31, 2023
AbbVies Rinvoq Succeeds Against The Odds In Phase II Lupus Trial
Despite a troubled history of JAK inhibitors in lupus trials, AbbVie’s Rinvoq has hit the mark in a mid-stage study...
Scrip - May 31, 2023
Despite a troubled history of JAK inhibitors in lupus trials, AbbVie’s Rinvoq has hit the mark in a mid-stage study...
Scrip - May 31, 2023
Stock Watch: Defeat Is The Mother Of Reinvention
Companies that are successful do not need to change their name, therapeutic area or product focus.
Scrip - May 31, 2023
Companies that are successful do not need to change their name, therapeutic area or product focus.
Scrip - May 31, 2023
Investor Eye: A Licensing-Based Approach May Be Best For Revolutionary IP
Keeping a firm grip on one’s IP is a cornerstone of most innovative businesses. However, Robert Cote, CEO of Cote...
Medtech Insight - May 31, 2023
Keeping a firm grip on one’s IP is a cornerstone of most innovative businesses. However, Robert Cote, CEO of Cote...
Medtech Insight - May 31, 2023
1 June Marks Historic Day For Patent Protection In Europe
The forthcoming unitary patent system and Unified Patent Court promise to make applying for patents in Europe and litigating infringements...
Pink Sheet - May 31, 2023
The forthcoming unitary patent system and Unified Patent Court promise to make applying for patents in Europe and litigating infringements...
Pink Sheet - May 31, 2023
International Regulators Focus On Omicron XBB For Monovalent COVID-19 Vaccine
A workshop led by the European Medicines Agency and the US Food and Drug Administration sought to reach alignment on...
Pink Sheet - May 31, 2023
A workshop led by the European Medicines Agency and the US Food and Drug Administration sought to reach alignment on...
Pink Sheet - May 31, 2023
Sanofi Moves Up In MS With Frexalimab Success
Much of the focus on the French major’s MS pipeline has been on the BTK inhibitor tolebrutinib but promising Phase...
Scrip - May 31, 2023
Much of the focus on the French major’s MS pipeline has been on the BTK inhibitor tolebrutinib but promising Phase...
Scrip - May 31, 2023
An Intelligent Approach To Pain Management
With all of the advancements in the life sciences industry, there is one area that is still assessed the way...
In Vivo - May 31, 2023
With all of the advancements in the life sciences industry, there is one area that is still assessed the way...
In Vivo - May 31, 2023
Addressing The Rare Disease Challenge Via Patient Engagement
Following the FDA’s release of draft guidance to enhance patient voice, In Vivo spoke with Ipsen’s rare disease regulation expert...
In Vivo - May 31, 2023
Following the FDA’s release of draft guidance to enhance patient voice, In Vivo spoke with Ipsen’s rare disease regulation expert...
In Vivo - May 31, 2023
UK Parliamentarians Call For A New, Internationally Competitive Pricing System
Much-needed investment could be lost if the “uncompetitive” sales rebate rate is not reduced as part of talks on a...
Pink Sheet - May 31, 2023
Much-needed investment could be lost if the “uncompetitive” sales rebate rate is not reduced as part of talks on a...
Pink Sheet - May 31, 2023
AESGP Annual Meeting: Sustainability Optional Now, But Not For Long, Warns Haleon
European consumer health companies today have the luxury of voluntarily setting sustainability goals. But with regulations looming and pressure from...
HBW Insight - May 31, 2023
European consumer health companies today have the luxury of voluntarily setting sustainability goals. But with regulations looming and pressure from...
HBW Insight - May 31, 2023
Algae With Claimed Immunity Benefits Gets EU Nod For Supplement Use
An algae extract that is claimed to support the immune system while helping to protect against oxidative stress has obtained...
HBW Insight - May 31, 2023
An algae extract that is claimed to support the immune system while helping to protect against oxidative stress has obtained...
HBW Insight - May 31, 2023
Is It Time To Promote US FDA’s Biosimilars Office Out Of OND?
Making the Office of Therapeutic Biologics and Biosimilars a stand-alone office in CDER may allow it to add more expertise...
Generics Bulletin - May 31, 2023
Making the Office of Therapeutic Biologics and Biosimilars a stand-alone office in CDER may allow it to add more expertise...
Generics Bulletin - May 31, 2023
UK LifeSci Funding Boost – Medtech Research And Regulation To Benefit
Rebranded Health Innovation Networks, Biobanks and clinical trials get share of £650m UK funding earmarked to support research, manufacturing, skills...
Medtech Insight - May 31, 2023
Rebranded Health Innovation Networks, Biobanks and clinical trials get share of £650m UK funding earmarked to support research, manufacturing, skills...
Medtech Insight - May 31, 2023
Travere Looks Ahead To Phase III In Homocystinuria
The latest data from a Phase I/II study shows that pegtibatinase can yield a rapid, sustained reduction in homocysteine, the...
Scrip - May 31, 2023
The latest data from a Phase I/II study shows that pegtibatinase can yield a rapid, sustained reduction in homocysteine, the...
Scrip - May 31, 2023
Trials In Focus: Diverse Enrollment Lagging In Oncology, IQVIA Finds
Also, CRO Syneos Health appointed an executive to its newly created DE&I position, while Alterity started a new Phase II...
Scrip - May 31, 2023
Also, CRO Syneos Health appointed an executive to its newly created DE&I position, while Alterity started a new Phase II...
Scrip - May 31, 2023
AbbVies Rinvoq Succeeds Against The Odds In Phase II Lupus Trial
Despite a troubled history of JAK inhibitors in lupus trials, AbbVie’s Rinvoq has hit the mark in a mid-stage study...
Scrip - May 31, 2023
Despite a troubled history of JAK inhibitors in lupus trials, AbbVie’s Rinvoq has hit the mark in a mid-stage study...
Scrip - May 31, 2023
Stock Watch: Defeat Is The Mother Of Reinvention
Companies that are successful do not need to change their name, therapeutic area or product focus.
Scrip - May 31, 2023
Companies that are successful do not need to change their name, therapeutic area or product focus.
Scrip - May 31, 2023
Sanofi Moves Up In MS With Frexalimab Success
Much of the focus on the French major’s MS pipeline has been on the BTK inhibitor tolebrutinib but promising Phase...
Scrip - May 31, 2023
Much of the focus on the French major’s MS pipeline has been on the BTK inhibitor tolebrutinib but promising Phase...
Scrip - May 31, 2023
The US VA And Alzheimer’s: A Misunderstood Decision
US Department of Veterans Affairs' head for pharmacy benefits management says her agency’s coverage of Leqembi and Aduhelm is actually...
Pink Sheet - May 31, 2023
US Department of Veterans Affairs' head for pharmacy benefits management says her agency’s coverage of Leqembi and Aduhelm is actually...
Pink Sheet - May 31, 2023
Janssen 340B Discount Growth Slowed In 2022 But Still Topped $6bn; Patient Assistance Jumps 24%
Janssen continues to pursue aggressive policies to reduce inappropriate use of 340B discounts. Firm estimates that 58% of list prices...
Pink Sheet - May 31, 2023
Janssen continues to pursue aggressive policies to reduce inappropriate use of 340B discounts. Firm estimates that 58% of list prices...
Pink Sheet - May 31, 2023
1 June Marks Historic Day For Patent Protection In Europe
The forthcoming unitary patent system and Unified Patent Court promise to make applying for patents in Europe and litigating infringements...
Pink Sheet - May 31, 2023
The forthcoming unitary patent system and Unified Patent Court promise to make applying for patents in Europe and litigating infringements...
Pink Sheet - May 31, 2023
International Regulators Focus On Omicron XBB For Monovalent COVID-19 Vaccine
A workshop led by the European Medicines Agency and the US Food and Drug Administration sought to reach alignment on...
Pink Sheet - May 31, 2023
A workshop led by the European Medicines Agency and the US Food and Drug Administration sought to reach alignment on...
Pink Sheet - May 31, 2023
UK Parliamentarians Call For A New, Internationally Competitive Pricing System
Much-needed investment could be lost if the “uncompetitive” sales rebate rate is not reduced as part of talks on a...
Pink Sheet - May 31, 2023
Much-needed investment could be lost if the “uncompetitive” sales rebate rate is not reduced as part of talks on a...
Pink Sheet - May 31, 2023
Minute Insight: Inbound Health Now Offers Post-Surgical Hospital Care At Patients’ Homes
The hospital-to-home care movement is rising, and Inbound Health wants to be at the forefront of enabling health systems and...
Medtech Insight - May 31, 2023
The hospital-to-home care movement is rising, and Inbound Health wants to be at the forefront of enabling health systems and...
Medtech Insight - May 31, 2023
FDA’s Power Morcellation Containment System Guidance Doc Finalized
The US FDA has finalized a guidance document that details performance assessment standards for power morcellation containment systems. The class...
Medtech Insight - May 31, 2023
The US FDA has finalized a guidance document that details performance assessment standards for power morcellation containment systems. The class...
Medtech Insight - May 31, 2023
Exec Chat: Abbott’s Burton Talks About Abbott’s Plans To Address Chronic Pain With SCS
Allen Burton, the medical director of Abbott’s neuromodulation business and a leader in pain medicine, talked to Medtech Insight about...
Medtech Insight - May 31, 2023
Allen Burton, the medical director of Abbott’s neuromodulation business and a leader in pain medicine, talked to Medtech Insight about...
Medtech Insight - May 31, 2023
Facility Inspection Leads To FDA Warning For iRhythm
The US FDA issued a warning letter to iRhythm Technologies related to its Zio cardiac monitor system after an August...
Medtech Insight - May 31, 2023
The US FDA issued a warning letter to iRhythm Technologies related to its Zio cardiac monitor system after an August...
Medtech Insight - May 31, 2023
Investor Eye: A Licensing-Based Approach May Be Best For Revolutionary IP
Keeping a firm grip on one’s IP is a cornerstone of most innovative businesses. However, Robert Cote, CEO of Cote...
Medtech Insight - May 31, 2023
Keeping a firm grip on one’s IP is a cornerstone of most innovative businesses. However, Robert Cote, CEO of Cote...
Medtech Insight - May 31, 2023
UK LifeSci Funding Boost – Medtech Research And Regulation To Benefit
Rebranded Health Innovation Networks, Biobanks and clinical trials get share of £650m UK funding earmarked to support research, manufacturing, skills...
Medtech Insight - May 31, 2023
Rebranded Health Innovation Networks, Biobanks and clinical trials get share of £650m UK funding earmarked to support research, manufacturing, skills...
Medtech Insight - May 31, 2023
Ulta Working To Combat Surging Retail Theft As Q1 Sales Rise 12.3%
Ulta Beauty says consumers are being more selective in their spending but show “continued willingness to splurge and treat themselves.”...
HBW Insight - May 31, 2023
Ulta Beauty says consumers are being more selective in their spending but show “continued willingness to splurge and treat themselves.”...
HBW Insight - May 31, 2023
AESGP Annual Meeting: Sustainability Optional Now, But Not For Long, Warns Haleon
European consumer health companies today have the luxury of voluntarily setting sustainability goals. But with regulations looming and pressure from...
HBW Insight - May 31, 2023
European consumer health companies today have the luxury of voluntarily setting sustainability goals. But with regulations looming and pressure from...
HBW Insight - May 31, 2023
Algae With Claimed Immunity Benefits Gets EU Nod For Supplement Use
An algae extract that is claimed to support the immune system while helping to protect against oxidative stress has obtained...
HBW Insight - May 31, 2023
An algae extract that is claimed to support the immune system while helping to protect against oxidative stress has obtained...
HBW Insight - May 31, 2023
Is It Time To Promote US FDA’s Biosimilars Office Out Of OND?
Making the Office of Therapeutic Biologics and Biosimilars a stand-alone office in CDER may allow it to add more expertise...
Generics Bulletin - May 31, 2023
Making the Office of Therapeutic Biologics and Biosimilars a stand-alone office in CDER may allow it to add more expertise...
Generics Bulletin - May 31, 2023
An Intelligent Approach To Pain Management
With all of the advancements in the life sciences industry, there is one area that is still assessed the way...
In Vivo - May 31, 2023
With all of the advancements in the life sciences industry, there is one area that is still assessed the way...
In Vivo - May 31, 2023
Addressing The Rare Disease Challenge Via Patient Engagement
Following the FDA’s release of draft guidance to enhance patient voice, In Vivo spoke with Ipsen’s rare disease regulation expert...
In Vivo - May 31, 2023
Following the FDA’s release of draft guidance to enhance patient voice, In Vivo spoke with Ipsen’s rare disease regulation expert...
In Vivo - May 31, 2023
